316 related articles for article (PubMed ID: 31691433)
21. Mitogen- and stress-activated Kinase 1 mediates Epstein-Barr virus latent membrane protein 1-promoted cell transformation in nasopharyngeal carcinoma through its induction of Fra-1 and c-Jun genes.
Li B; Wan Z; Huang G; Huang Z; Zhang X; Liao D; Luo S; He Z
BMC Cancer; 2015 May; 15():390. PubMed ID: 25958199
[TBL] [Abstract][Full Text] [Related]
22. Wild-type IDH2 contributes to Epstein-Barr virus-dependent metabolic alterations and tumorigenesis.
Shi F; He Y; Li J; Tang M; Li Y; Xie L; Zhao L; Hu J; Luo X; Zhou M; Liu N; Fan J; Zhou J; Gao Q; Qiu S; Wu W; Zhang X; Jia W; Bode AM; Cao Y
Mol Metab; 2020 Jun; 36():100966. PubMed ID: 32224436
[TBL] [Abstract][Full Text] [Related]
23. LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells.
Liu H; Zheng H; Duan Z; Hu D; Li M; Liu S; Li Z; Deng X; Wang Z; Tang M; Shi Y; Yi W; Cao Y
Mol Cancer; 2009 Oct; 8():92. PubMed ID: 19860880
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma.
Kondo S; Wakisaka N; Schell MJ; Horikawa T; Sheen TS; Sato H; Furukawa M; Pagano JS; Yoshizaki T
Int J Cancer; 2005 Jun; 115(3):368-76. PubMed ID: 15688379
[TBL] [Abstract][Full Text] [Related]
25. Increased phosphorylation of histone H3 at serine 10 is involved in Epstein-Barr virus latent membrane protein-1-induced carcinogenesis of nasopharyngeal carcinoma.
Li B; Huang G; Zhang X; Li R; Wang J; Dong Z; He Z
BMC Cancer; 2013 Mar; 13():124. PubMed ID: 23496845
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus oncoprotein LMP1 mediates survivin upregulation by p53 contributing to G1/S cell cycle progression in nasopharyngeal carcinoma.
Guo L; Tang M; Yang L; Xiao L; Bode AM; Li L; Dong Z; Cao Y
Int J Mol Med; 2012 Apr; 29(4):574-80. PubMed ID: 22266808
[TBL] [Abstract][Full Text] [Related]
27. Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.
Li J; Zhang XS; Xie D; Deng HX; Gao YF; Chen QY; Huang WL; Masucci MG; Zeng YX
Cancer Biol Ther; 2007 Dec; 6(12):1997-2004. PubMed ID: 18087217
[TBL] [Abstract][Full Text] [Related]
28. Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance.
Xie L; Shi F; Li Y; Li W; Yu X; Zhao L; Zhou M; Hu J; Luo X; Tang M; Fan J; Zhou J; Gao Q; Wu W; Zhang X; Liao W; Bode AM; Cao Y
Signal Transduct Target Ther; 2020 May; 5(1):56. PubMed ID: 32433544
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus-encoded LMP1 interacts with FGD4 to activate Cdc42 and thereby promote migration of nasopharyngeal carcinoma cells.
Liu HP; Chen CC; Wu CC; Huang YC; Liu SC; Liang Y; Chang KP; Chang YS
PLoS Pathog; 2012; 8(5):e1002690. PubMed ID: 22589722
[TBL] [Abstract][Full Text] [Related]
30. Association of Plasma Epstein-Barr Virus LMP1 and EBER1 with Circulating Tumor Cells and the Metastasis of Nasopharyngeal Carcinoma.
Sun L; Wang Y; Shi J; Zhu W; Wang X
Pathol Oncol Res; 2020 Jul; 26(3):1893-1901. PubMed ID: 31832991
[TBL] [Abstract][Full Text] [Related]
31. Anoikis resistance and immune escape mediated by Epstein-Barr virus-encoded latent membrane protein 1-induced stabilization of PGC-1α promotes invasion and metastasis of nasopharyngeal carcinoma.
Liao C; Li M; Chen X; Tang C; Quan J; Bode AM; Cao Y; Luo X
J Exp Clin Cancer Res; 2023 Oct; 42(1):261. PubMed ID: 37803433
[TBL] [Abstract][Full Text] [Related]
32. Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy.
Lechner M; Schartinger VH; Steele CD; Nei WL; Ooft ML; Schreiber LM; Pipinikas CP; Chung GT; Chan YY; Wu F; To KF; Tsang CM; Pearce W; Morelli D; Philpott M; Masterson L; Nibhani R; Wells G; Bell CG; Koller J; Delecluse S; Yip YL; Liu J; Forde CT; Forster MD; Jay A; Dudás J; Krapp A; Wan S; Uprimny C; Sprung S; Haybaeck J; Fenton TR; Chester K; Thirlwell C; Royle G; Marafioti T; Gupta R; Indrasari SR; Herdini C; Slim MAM; Indrawati I; Sutton L; Fles R; Tan B; Yeong J; Jain A; Han S; Wang H; Loke KSH; He W; Xu R; Jin H; Cheng Z; Howard D; Hwang PH; Le QT; Tay JK; West RB; Tsao SW; Meyer T; Riechelmann H; Oppermann U; Delecluse HJ; Willems SM; Chua MLK; Busson P; Lo KW; Wollmann G; Pillay N; Vanhaesebroeck B; Lund VJ
Nat Commun; 2021 Jan; 12(1):117. PubMed ID: 33402692
[TBL] [Abstract][Full Text] [Related]
33. EB virus promotes metastatic potential by boosting STIM1-dependent Ca
Wei J; Ye J; Luo Y; Weng J; He Q; Liu F; Li M; Lin Y; Li Y; Zhang Z; Qu S; Zhang J
Cancer Lett; 2020 May; 478():122-132. PubMed ID: 32165272
[TBL] [Abstract][Full Text] [Related]
34. Modified Anoikis Assay That Functionally Segregates Epstein-Barr Virus LMP1 Strains into Two Groups.
Wasil LR; Shair KHY
J Virol; 2018 Sep; 92(18):. PubMed ID: 29950426
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional repression of tissue inhibitor of metalloproteinase-3 by Epstein-Barr virus latent membrane protein 1 enhances invasiveness of nasopharyngeal carcinoma cells.
Chang SH; Chang HC; Hung WC
Oral Oncol; 2008 Sep; 44(9):891-7. PubMed ID: 18289921
[TBL] [Abstract][Full Text] [Related]
36. LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma.
Cai TT; Ye SB; Liu YN; He J; Chen QY; Mai HQ; Zhang CX; Cui J; Zhang XS; Busson P; Zeng YX; Li J
PLoS Pathog; 2017 Jul; 13(7):e1006503. PubMed ID: 28732079
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus-encoded latent membrane protein 1 promotes extracellular vesicle secretion through syndecan-2 and synaptotagmin-like-4 in nasopharyngeal carcinoma cells.
Liao C; Zhou Q; Zhang Z; Wu X; Zhou Z; Li B; Peng J; Shen L; Li D; Luo X; Yang L
Cancer Sci; 2020 Mar; 111(3):857-868. PubMed ID: 31930596
[TBL] [Abstract][Full Text] [Related]
38. [Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus LMP1 via NF-kappa B or AP-1 signaling pathway in nasopharyngeal carcinoma cells].
Wang C; Deng X; Li X; Gu H; Yi W; Weng X; Xia L; Cao Y
Zhonghua Zhong Liu Za Zhi; 2002 Jan; 24(1):9-13. PubMed ID: 11977651
[TBL] [Abstract][Full Text] [Related]
39. Modulation of the tumor microenvironment by Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma.
Yoshizaki T; Kondo S; Endo K; Nakanishi Y; Aga M; Kobayashi E; Hirai N; Sugimoto H; Hatano M; Ueno T; Ishikawa K; Wakisaka N
Cancer Sci; 2018 Feb; 109(2):272-278. PubMed ID: 29247573
[TBL] [Abstract][Full Text] [Related]
40. Repression of DERL3 via DNA methylation by Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma.
Kondo S; Okabe A; Nakagawa T; Matsusaka K; Fukuyo M; Rahmutulla B; Dochi H; Mizokami H; Kitagawa Y; Kurokawa T; Mima M; Endo K; Sugimoto H; Wakisaka N; Misawa K; Yoshizaki T; Kaneda A
Biochim Biophys Acta Mol Basis Dis; 2023 Feb; 1869(2):166598. PubMed ID: 36372158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
